Captiox, LLC — SEC Form D Filing

Captiox, LLC filed an SEC Form D on August 14, 2026, reporting $2.35M raised in Healthcare Technology.

Form D filing details

Filing
SEC Form D
Filing date
August 14, 2026
Amount reported
$2.35M
Round stage
Seed stage because a $2.35 million raise is typical for early-stage product development and initial market validation.
Industry
Healthcare Technology
Website
https://captiox.com

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Healthcare providers struggle with inefficient clinical workflows and administrative burdens that reduce patient care quality.

Solution

Captiox develops a proprietary software platform that streamlines clinical data management and automates administrative workflows for healthcare providers.

Why now

The rapid adoption of digital health records and increasing regulatory pressure to improve clinical efficiency demand advanced interoperable software solutions.

Verdict

This cleared because investors were willing to make a small bet on general healthcare innovation without specific proof points, not because the company articulated a novel problem or solution. Investors implicitly bet on the founders' ability to identify and execute on a viable niche within a large, recognized market, assuming future clarity would emerge. This approach limited upside by delaying valuation step-ups until a more concrete and differentiated offering could be presented.

Source: SEC EDGAR Form D filing